The global intrauterine contraceptive devices market refers to a device known as the IUD (intrauterine contraceptive device), which is inserted into the uterus to prevent contraception. The IUD can be a loop, coil, triangle, or T in shape made of metal or plastic. The IUD is inserted into the uterus by a health-care professional. The IUD prevents eggs and sperm from gathering by either changing the uterine lining so the fertilized egg cannot implant in it or by immobilizing the sperm on their way to the fallopian tubes. The global intrauterine contraceptive devices market created an amount of $XX billion in 2018 and is anticipated to create $5,253 billion by the end of 2027, at a CAGR of 3.87%. For the market study, 2018 is taken into account as the base year, while the forecasted years are between 2019 and 2027.

Key factors that are influencing the global intrauterine contraceptive devices market advancement are:

• Government initiatives focusing on improved healthcare in Asian countries
• Technological advancements in intrauterine contraceptive devices
• Rising prevalence of unplanned pregnancy

To know more about this report, request a free sample copy.

The global intrauterine contraceptive devices market is majorly driven by the numerous government initiatives and family planning programs. The lack of awareness, coupled with a rapid increase in cases of unprotected sex, are the prime factors that are fueling the growth of the market. The low literacy rate and the dearth of quality education are other drivers that are pushing the market growth in the forecast period 2019-2027.

In 2018, the product Paragard in the intrauterine contraceptive devices market captured the largest share of 53.52% in the product segment. The intrauterine contraceptive devices market in Paragard is driven by a rise in research and development activities along with the introduction of innovative products. This is fueling the growth of this product segment during the forecast period. Further, the low prices of raw materials and the rising adoption of strategic initiatives by the company also boost the company’s growth.

Further, the increasing demand for ICD devices is also spreading the growth projections for this segment together with large investments in research and development and mergers, which is boosting the growth of the intrauterine contraceptive devices market in the estimated period. Though the adoption of ICD devices is growing, the global market faces some challenges and restraints. The high cost of treatment, and the low adoption of ICD devices due to a growing stigma, is limiting the growth of the intrauterine contraceptive devices market in the forecast period 2019-2027. Besides, the growing concerns regarding the side effects are also affecting the growth of the market in the forecast period.

Report scope of global intrauterine contraceptive devices market covers segments by region, product, and type.

Market by Type:

• Copper ICD
• Hormonal ICD

Market by Product:

• Mirena
• Skyla
• Paragard
• Other product

Based on Geography, the global intrauterine contraceptive devices market has been segmented on the basis of four major regions, which are:

• North America: The United States and Canada
• Europe: United Kingdom, France, Germany, Italy, Spain, and Rest of Europe
• Asia-Pacific: Japan, China, South Korea, India, Australia, & Rest of Asia Pacific
• Rest of World: Latin America, Middle East & Africa

The Asia Pacific region is the leading region for the intrauterine contraceptive devices market, with around 36% market share in 2018 in terms of revenue. The dominance of Asia Pacific is ascribed to the fact of the presence of the majority of the key players that are offering the services in the region. The key players are Allergan PLC, Bayers AG, Pfizer, and many others.

Further, the Asia-Pacific intrauterine contraceptive device market is rising rapidly owing to the increasing number of unplanned pregnancies coupled with the growing demand for economical contraceptive devices in the region is boosting the growth of the global market in the forecast period 2019-2027. According to the International Planned Parenthood Federation (IPPF) study, women who used ICD had nearly half the threat of getting cervical cancer, which is driven by the infection of sexually transmitted human papillomavirus (HPV). The women in the region are becoming more aware of the contraceptive devices, which is also furthering the growth of the intrauterine contraceptive device market in the Asia Pacific region.

Asia Pacific is also the fastest-growing region throughout the forecast period. The fastest growth rate of the Asia Pacific region attributes to aspects such as the increasing cases of unplanned pregnancy, and the rise in research and development spending. This is also boosting the growth in emerging economies of India, Indonesia, China, Japan, and Thailand.

Merck KGAA has entered into a distribution agreement with Grunenthal Group, a pharmaceutical company, for the company’s Women’s Health products in Brazil, Central America, Colombia, Mexico and Peru. This will further enlarge the intrauterine contraceptive devices market worldwide. Also, the projects of research & development in IUD devices are largely supported by the Indian government, which will further fuel the market growth in this region.

The global intrauterine contraceptive devices market has been segmented by type, product, and region. The product segment is further segmented into Mirena, Skyla, Paragard, and other products. Type comprises of Copper ICD and Hormonal ICD.

The market has a number of players, and some of the key players involved in the global intrauterine contraceptive devices market are:

• Merck KGAA
• OCON Medical Ltd.
• Pfizer
• Allergan PLC
• Other companies

In the report, the company profiles of eminent market players are discussed in detail. Many of these companies are seeking corporate strategies such as partnerships, merger & acquisition, new product launch, agreements, and contracts, to gain a competitive edge over each other. For instance, in January 2018, Power and Medicines360 have entered into a partnership to increase the accessibility of contraception to all women. This partnership aims, especially to help the more than 19 million women who live in contraceptive methods.

Key findings of the global intrauterine contraceptive devices market:

• The Asia Pacific leads the global intrauterine contraceptive devices market by capturing the largest market share of around 36% in 2018.
• The focus of market players is to increase awareness regarding IUDs, coupled with the innovation of new products.
• The Asia Pacific intrauterine contraceptive devices market is anticipated to grow at the highest CAGR of XX% during the forecast period.
• Growth in the unplanned pregnancies is boosting the growth of the market in the forecast period.
• The demand for hormonal ICD is boosting the growth of the market in the forecast period.